The predictive role of the hs-CRP/HDL-C ratio for long-term mortality in the general population: evidence from a cohort study

被引:4
作者
Wang, Yifeng [1 ]
Wang, Li [2 ]
Zhao, Zongquan [2 ]
Yin, Song [2 ]
Tang, Xuejun [2 ]
Zhang, Kerui [3 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing 210000, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Suzhou Municipal Hosp, Community Hlth Ctr, Gusu Sch,Affiliated Suzhou Hosp, Suzhou 215000, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou Municipal Hosp, Gusu Sch,Ctr Cardiovasc Dis, Suzhou 215000, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
hs-CRP; HDL-C; Long-term mortality; NHANES; Correlational analysis; HIGH-DENSITY-LIPOPROTEIN; ALL-CAUSE MORTALITY; REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; HDL CHOLESTEROL; RISK; ASSOCIATION; ATHEROSCLEROSIS; INFLAMMATION; HEALTH;
D O I
10.1186/s12872-024-04446-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The high-sensitivity C-reactive protein (hs-CRP) to high-density lipoprotein cholesterol (HDL-C) ratio, a composite marker of low-grade inflammation and lipid metabolism, is reportedly associated with the occurrence of new cardiovascular diseases (CVDs) in certain people. However, the predictive value of the hs-CRP/HDL-C ratio for long-term mortality in the general population remains unclear. Methods This retrospective cohort study included data from 9,492 adults obtained from the National Health and Nutrition Examination Survey (NHANES) (2015-2018) in the United States. Multivariate Cox regression, two-piecewise linear regression, restricted cubic spline (RCS) models and subgroup analysis by age, sex, smoking status and drinking status were applied to evaluate the associations of the hs-CRP/HDL-C ratio with long-term all-cause and cardiovascular mortality. Results The overall median age of the cohort was 47.0 years (interquartile range (IQR) 32.0-62.0), and 4,585 (48.30%) patients were male. During a median follow-up period of 37.0 months, 239 (2.52%) all-cause deaths occurred, 59 (0.62%) of which were attributed to cardiovascular events. Participants with all-cause and cardiovascular mortality presented a higher hs-CRP/HDL-C ratio than did those without events [0.56 (0.24-1.38) vs. 0.37 (0.14-0.94) and 0.60 (0.23-1.60) vs. 0.37 (0.14-0.95), P < 0.001 and P = 0.002]. According to multivariate Cox regression models, the hs-CRP/HDL-C ratio was found to be an independent risk factor for both long-term all-cause mortality [hazard ratio (HR) = 1.09, 95% confidence interval (CI): 1.05-1.13] and cardiovascular mortality (HR = 1.11, 95% CI: 1.05-1.19). A two-piecewise linear regression model indicated that the risk of all-cause mortality increased more prominently when the hs-CRP/HDL-C ratio was less than 1.21. In addition, a significant interaction effect with smoking status was discovered (P = 0.006), indicating that the association of the hs-CRP/HDL-C ratio with all-cause mortality was stronger in nonsmokers. The RCS curve revealed a positive linear association of the hs-CRP/HDL-C ratio with long-term mortality after adjustment for potential confounders. Conclusions The hs-CRP/HDL-C ratio is a crucial predictor of long-term mortality in the general population, independent of potential confounding factors.
引用
收藏
页数:13
相关论文
共 67 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]   Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer [J].
Allin, Kristine H. ;
Bojesen, Stig E. ;
Nordestgaard, Borge G. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (13) :2217-2224
[3]   C-reactive protein as a screening test for cardiovascular risk in a multiethnic population [J].
Anand, SS ;
Razak, F ;
Yi, QL ;
Davis, B ;
Jacobs, R ;
Vuksan, V ;
Lonn, E ;
Teo, K ;
McQueen, M ;
Yusuf, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) :1509-1515
[4]   HDL cholesterol and protective factors in atherosclerosis [J].
Assmann, G ;
Gotto, AM .
CIRCULATION, 2004, 109 (23) :8-14
[5]   C-Reactive Protein in Atherothrombosis and Angiogenesis [J].
Badimon, Lina ;
Pena, Esther ;
Arderiu, Gemma ;
Padro, Teresa ;
Slevin, Mark ;
Vilahur, Gemma ;
Chiva-Blanch, Gemma .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[6]   Interactive effect of increased high sensitive C-reactive protein and dyslipidemia on cardiovascular diseases: a 12-year prospective cohort study [J].
Bafei, Solim Essomandan Clemence ;
Zhao, Xianghai ;
Chen, Changying ;
Sun, Junxiang ;
Zhuang, Qian ;
Lu, Xiangfeng ;
Chen, Yanchun ;
Gu, Xincheng ;
Liu, Fangyuan ;
Mu, Jialing ;
Wei, Lai ;
Wei, Pengfei ;
Yin, Yunjie ;
Xie, Hankun ;
Yang, Song ;
Shen, Chong .
LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
[7]   Role of High-Sensitivity C-reactive Protein (Hs-CRP) in Non-communicable Diseases: A Review [J].
Banait, Tanvi ;
Wanjari, Anil ;
Danade, Vedika ;
Banait, Shashank ;
Jain, Jyoti .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
[8]   Cardiovascular Inflammaging: Mechanisms and Translational Aspects [J].
Barcena, Maria Luisa ;
Aslam, Muhammad ;
Pozdniakova, Sofya ;
Norman, Kristina ;
Ladilov, Yury .
CELLS, 2022, 11 (06)
[9]  
Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI [10.1161/CIR.0000000000000659, 10.1161/CIR.0000000000000746]
[10]   CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease - Application to Clinical and Public Health Practice - Clinical use of inflammatory markers in patients with cardiovascular diseases - A background paper [J].
Biasucci, LM .
CIRCULATION, 2004, 110 (25) :E560-E567